Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer

Kirsten rat sarcoma viral oncogene homologue (KRAS) is a frequent oncogenic driver of solid tumors, including non-small cell lung cancer (NSCLC). The treatment and outcomes of KRAS-mutant cancers have not been dramatically revolutionized by direct KRAS-targeted therapies because of the lack of deep...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Dong Hoon, Jo, Jeong Yeon, Choi, Minyoung, Kim, Kyung-Hee, Bae, Young-Ki, Kim, Sang Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618295/
https://www.ncbi.nlm.nih.gov/pubmed/37779142
http://dx.doi.org/10.1038/s12276-023-01091-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618295/
https://www.ncbi.nlm.nih.gov/pubmed/37779142
http://dx.doi.org/10.1038/s12276-023-01091-0

Ejemplares similares